(2aE,2′R,2a1S,4E,5′S,6R,6′R,8E,11R,15S,17aR,20Z,20aR)-2a1-hydroxy-20-(hydroxyimino)-5′,6,8,19-tetramethyl-6′-(1-methylethyl)-2a1,3′,4′,5′,6,6′,7,10,11,14,15,17a,20,20a-tetradecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2′-pyran]-17-one (milbemycin D oxime),
Milbemycin EP Impurity G is a fully characterized chemical compound used as a reference standard of API Milbemycin. The standard offered is compliant with regulatory guidelines. Milbemycin EP Impurity G is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 93074-02-3
Related products
Milbemycin Oxime (Mixture of Milbemycin Oxime A3 and A4)
M.F.
M.W. 541.69
CAT# AR-M04690
CAS# 129496-10-2
